SELLAS Life Sciences Group, Inc. (RXK3)
FSX
9.92
-0.08 (-0.80%)
Closed
Oct 9, 2026
Day's Range
9.929.92
52 wk Range
1.2014.95
Financial Statements - RXK3 - SELLAS Life Sciences Group, Inc.
Revenue
0
Net Income
-26.86M▲ 13.0%
EBITDA
-28.27M▲ 10.3%
Free Cash Flow
-28.38M▲ 19.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 1M | 7.60M | 1.90M |
| Cost of Goods | - | - | 0 | 100K | 200K | 0 |
| Gross Profit | - | - | 0 | 900K | 7.40M | 1.90M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -28.27M | -31.51M | -37.86M | -31.95M | -19.59M | -16.98M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | 4K | -9.66M | -1.34M | 182K |
| Pre Tax Income | -26.86M | -30.88M | -37.34M | -41.30M | -20.93M | -16.77M |
| Income Tax | - | - | - | 0 | -237K | -17K |
| Net Income | -26.86M | -30.88M | -37.34M | -41.30M | -20.69M | -16.75M |
| EPS Basic | -0.25 | -0.5 | -1.34 | -2.13 | -1.34 | -2.11 |
| EPS Diluted | -0.25 | -0.5 | -1.34 | -2.13 | -1.34 | -2.11 |
| Basic Shares Outstanding | 109.05M | 61.20M | 30.12M | 19.91M | 15.89M | 8.19M |
| Diluted Shares Outstanding | 109.05M | 61.20M | 30.12M | 19.91M | 15.89M | 8.19M |
| Ebit | -28.27M | -31.51M | -37.86M | -31.95M | -19.59M | -16.98M |
| Ebitda | -28.27M | -31.51M | -37.87M | -22.28M | -18.24M | -17.16M |
| Net Income Continuous Operations | -26.86M | -30.88M | -37.34M | -41.30M | -20.69M | -16.75M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | 0 | 78K |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
